Organization · Venture Capital
FundRx
MBX Capital, formerly known as FundRx, is an early-stage venture capital firm based in the United States that invests in innovative healthcare and life sciences companies. The firm employs a scientific approach to investing, leveraging a network of experts to guide its portfolio.
Overview
What FundRx does
What FundRx is
MBX Capital, formerly known as FundRx, is an early-stage venture capital firm based in the United States that invests in innovative healthcare and life sciences companies. The firm employs a scientific approach to investing, leveraging a network of experts to guide its portfolio.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2021
- Approximate age
- About 5 years
- Structured capabilities
- Funder
- Last reviewed
- March 30, 2026
Official channels
Find FundRx elsewhere
Open the official website or a supported primary organization account.
Capability profile
FundRx as a funder
Investment thesis
MBX Capital focuses on deep health innovations, investing in early-stage companies that address complex healthcare challenges through advanced technologies in biology, chemistry, AI, and robotics.
Focus narrative
MBX Capital invests in early-stage companies within the deep health sector, targeting innovative solutions in drug formulation, chronic disease detection, genetic testing, and mental healthcare. The firm emphasizes collaboration with co-investors and leverages its expert network to drive advancements in healthcare technology.
Value beyond capital
MBX Capital adds value to its portfolio companies through access to a vast network of scientific and clinical experts, facilitating strategic partnerships and collaborations. The firm provides not only capital but also insights and guidance in navigating the complex healthcare landscape, enhancing the potential for successful outcomes.
Terms and economics
- Typical check
- $1,000,000–$2,500,000
- Sweet spot
- $1,500,000
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Sectors
- Healthcare · Biotech · Medical Devices
- Regions
- North America
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 20
Portfolio context
Notable portfolio companies include: Persist AI: AI and robotics for faster drug formulation screening. Enoda Cellworks: Engineered receptors for controlling cell signaling. Juniper: Preimplantation genetic testing for IVF. Keebler Health: AI for chronic disease detection. Tidal Vision: Green chemistry solutions for pollution abatement. Junction Health: Infrastructure for infusion therapy in community health centers. Examol: Cloud infrastructure for computational chemistry. Vivodyne: Organoids-on-a-chip technology for toxicology. Macro Trials: Enhancing the speed and inclusivity of clinical trials. Arine: Comprehensive medication management solutions.
Common questions
What to know about FundRx
Upseed classifies FundRx under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 30, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.